Ser1155

Site Information
DEGKKEtsPEsSLIQ SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 456420

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 , 4 )
Disease tissue studied:	Alzheimer's disease ( 4 ) , lung cancer ( 1 , 3 ) , non-small cell lung adenocarcinoma ( 1 ) , FTLD ( 2 )
Relevant cell line - cell type - tissue:	'brain, cerebral cortex' ( 2 , 4 ) , CL1-0 (pulmonary) ( 3 ) , CL1-1 (pulmonary) ( 3 ) , CL1-2 (pulmonary) ( 3 ) , CL1-5 (pulmonary) ( 3 ) , lung ( 1 )

Upstream Regulation
Treatments:	metastatic potential ( 3 )

References
1	Schweppe DK, Rigas JR, Gerber SA (2013) Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors. J Proteomics 91, 286-96 23911959 Curated Info
2	Herskowitz JH, et al. (2010) Phosphoproteomic Analysis Reveals Site-Specific Changes in GFAP and NDRG2 Phosphorylation in Frontotemporal Lobar Degeneration. J Proteome Res 9, 6368-79 20886841 Curated Info
3	Wang YT, et al. (2010) An informatics-assisted label-free quantitation strategy that depicts phosphoproteomic profiles in lung cancer cell invasion. J Proteome Res 9, 5582-97 20815410 Curated Info
4	Xia Q, et al. (2008) Phosphoproteomic analysis of human brain by calcium phosphate precipitation and mass spectrometry. J Proteome Res 7, 2845-51 18510355 Curated Info